Skip to main content

NMR in Drug Discovery – Introduction

  • Reference work entry
Encyclopedia of Biophysics

Synonyms

Ligand-binding interactions; NMR; Target and hit validation techniques

Definition

Processes by which drugs are discovered and designed with analytical techniques such as NMR.

Introduction

Drug discovery is an ongoing and challenging process that is fraught with failure, but the successes have had profound impacts on human health. Fundamentally, drug discovery is a multidisciplinary endeavor requiring, among others, bioinformatics and computational chemistry, cell biology, medicinal chemistry, enzymology, high-throughput screening (HTS), molecular biology, protein chemistry, genomics and other “omics” technologies, and structural biology. Drug discovery is also an iterative procedure comprising four stages: target identification and validation, lead discovery, lead optimization, and clinical trials (Betz et al. 2006). In general, the drug discovery process starts by identifying a protein target associated with drug resistance, the progression or pathology of a disease, or the...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Betz M, Saxena K, et al. Biomolecular NMR: a chaperone to drug discovery. Curr Opin Chem Biol. 2006;10(3):219–25.

    CAS  PubMed  Google Scholar 

  • Bohacek RS, McMartin C, et al. The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev. 1996;16(1):3–50.

    CAS  PubMed  Google Scholar 

  • Bylesjo M, Rantalainen M, et al. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom. 2006;20(8–10):341–51.

    Google Scholar 

  • Fejzo J, Lepre CA, et al. The SHAPES strategy: an NMR-based approach for lead generation in drug discovery. Chem Biol. 1999;6(10):755–69.

    CAS  PubMed  Google Scholar 

  • Hadjduk J, Greer J. A decade of fragment-based drug design: stratigeic advances and leassons learned. Nat Rev Drug Discov. 2007;6:211–19.

    Google Scholar 

  • Halouska S, Fenton RJ, et al. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem Biol. 2012;7(1):166–71.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Heller M, Kessler H. NMR spectroscopy in drug design. Pure Appl Chem. 2001;73(9):1429–36.

    CAS  Google Scholar 

  • Kanelis V, Forman-Kay JD, et al. Multidimensional NMR methods for protein structure determination. IUBMB Life. 2001;52(6):291–302.

    CAS  PubMed  Google Scholar 

  • Lewis IA, Schommer SC, et al. Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H-13C NMR spectra. Anal Chem. 2007;79(24):9385–90.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Light DW, Warburton R. Demythologizing the high costs of pharmaceutical research. Biosocieties. 2011;6(1):34–50.

    Google Scholar 

  • Lipinski C. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–41.

    CAS  Google Scholar 

  • Pellecchia M, Sem DS, et al. NMR in drug discovery. Nat Rev Drug Discov. 2002;1(3):211–9.

    CAS  PubMed  Google Scholar 

  • Pellecchia M, Bertini I, et al. Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov. 2008;7(9):738–45.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Powers R. NMR metabolomics and drug discovery. Magn Reson Chem MRC. 2009;47(Suppl 1):S2–11.

    CAS  Google Scholar 

  • Powers R, Mercier KA, et al. The application of FAST-NMR for the identification of novel drug discovery targets. Drug Discov Today. 2008;13(3–4):172–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Roberts GCK. Applications of NMR in drug discovery. Drug Discov Today. 2000;5(6):230–40.

    CAS  PubMed  Google Scholar 

  • Shortridge MD, Hage DS, et al. Estimating protein-ligand binding affinity using high-throughput screening by NMR. J Comb Chem. 2008;10(6):948–58.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Stark JL, Mercier KA, et al. Solution structure and function of YndB, an AHSA1 protein from Bacillus subtilis. Proteins. 2010;78(16):3328–40.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Stoyanova R, Brown TR. NMR spectral quantitation by principal component analysis. III. A generalized procedure for determination of lineshape variations. J Magn Reson. 2002;154(2):163–75.

    CAS  PubMed  Google Scholar 

  • Widmer H, Jahnke W. Protein NMR in biomedical research. Cell Mol Life Sci CMLS. 2004;61(5):580–99.

    CAS  Google Scholar 

  • Zartler ER, Shapiro MJ. Fragonomics: fragment-based drug discovery. Curr Opin Chem Biol. 2005;9(4):366–70.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Halouska .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 European Biophysical Societies' Association (EBSA)

About this entry

Cite this entry

Halouska, S., Powers, R. (2013). NMR in Drug Discovery – Introduction. In: Roberts, G.C.K. (eds) Encyclopedia of Biophysics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16712-6_305

Download citation

Publish with us

Policies and ethics